AHIS, Alliance for Health Implementation Science

Initiatives / GRAFT / Transplant Eligibility Pilot

Donation & TransplantAccess gapIn development

Transplant Eligibility Pilot · ISP 2026007

A support barrier shouldn't end a transplant evaluation.

Increase access to transplant evaluation by helping transplant programs put existing and emerging approaches to modifiable caregiver and social-support barriers into practice.

Program snapshot
Program ID
ISP 2026007
Initiative
GRAFT · Transplant access
Duration
16 weeks per activated hub
Geography
Multi-center, U.S.
Implementation hubs
2 or more transplant programs
Status
In development

Why this program

The case for acting now.

1
The challenge

Patients may face delays in transplant evaluation when caregiver or social-support requirements can't be met through traditional support models.

2
The opportunity

GRAFT helps transplant programs implement approaches that address support barriers, so appropriate patients can continue evaluation.

3
Why now

Existing efforts are advancing solutions to caregiver and social-support barriers, creating an opportunity to move them into real-world practice.

Who it's for

The people this program serves.

Patients being considered for transplant whose evaluation may be delayed or limited by a caregiver or social-support barrier that can be addressed.

Priority indicators

Caregiver gapTransportationHousingMedication managementCare coordination

In their words

  • “As someone considering transplant, I want support needs identified before they prevent me from moving forward.
  • “As someone without a traditional caregiver, I want my support needs assessed, not my family structure.
  • “As someone receiving support, I want my transplant team to know when my needs have been addressed.

The journey

Every step, from start to finish.

Each Implementation Support Program finds what works and scales it rapidly. Here is the path this one follows.

1IdentifiedA potential supportbarrier is identified2AssessedSpecific supportneeds arecharacterized3SupportedAn individualizedsupport plan isactivated4ReassessedThe transplantprogram reassessesrequirements5ContinuedThe patient continuesevaluation

What it involves

Barriers in, support out.

Barriers we address
  • No designated caregiver
  • Limited caregiver availability
  • Transportation limitations
  • Temporary housing needs
  • Medication management
  • Care coordination needs
How the program helps
  • Support-needs assessment
  • Individualized support activation
  • Connection to existing and emerging resources
  • Return to the transplant program for reassessment
  • Shared learning across hubs
Implementation hubs
2 or more transplant programs
Support partners
5 or more advocacy, community and support organizations

What we measure

Every step, measured.

Primary measure
Continued
evaluation for patients after support is activated

Also measured

  • Support barriers identified
  • Support activated
  • Barriers resolved
  • Patients reassessed
  • Time to reassessment

Timeline

16 weeks per hub, from activation to impact report.

Week 2
Hub activated
GRAFT integrated into the existing workflow
Week 4
Preliminary results
First patients identified and assessed
Weeks 5 to 16
Implementation
Support activated and patients reassessed
Completion
Impact report
Outcomes and recommendations for scale

Timing depends on partner alignment and on governance, protocol and IRB requirements.

Our commitments

Independent and non-promotional.

Transplant eligibility and clinical decisions remain with transplant programs, patients and their healthcare professionals. GRAFT does not suggest caregiver requirements are unnecessary, and it does not guarantee eligibility or access.

Implementation Support Programs are sponsored separately from AHIS campaigns, and every sponsor is named here once an agreement is signed. The program follows a defined protocol, run under AHIS governance and the MONARCH operating standard for implementation measurement. Sponsors may help identify implementation challenges, populations or outcomes of interest. Design, governance and evaluation stay independent. Sponsors receive aggregate, de-identified results only.

Overseen by the AHIS Board in Phase 1 of AHIS governance, and by the Implementation Advisory Committee from Phase 2. Impact reports are shared publicly, including what didn't work.

How we stay independent

Get involved.

Join as a transplant implementation hub or a support partner.

Schedule a discovery callIdentify a gapSee the initiative